Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Medical Officer sold 5,617 shares at $8.56 ($48,082)
  3. 4 Grant or award See Remarks acquired 16,696 shares (grant or award)
  4. 4 Grant or award See Remarks acquired 25,311 shares (grant or award)
  5. 4 Grant or award Chief Operating Officer acquired 40,315 shares (grant or award)
  6. 4 Grant or award Chief Medical Officer acquired 22,307 shares (grant or award)
  7. 4 Grant or award See Remarks acquired 118,190 shares (grant or award)
  8. 4 Grant or award Chief Scientific Officer acquired 36,524 shares (grant or award)
  9. 4 Gift See Remarks gave 3,500 shares (gift)
  10. 4 Open-market sale Chief Operating Officer sold 2,451 shares at $17.22 ($42,206)
  11. 4 Open-market sale See Remarks sold 859 shares at an average $15.90 ($13,655)
  12. 4 Open-market sale See Remarks sold 1,274 shares at an average $15.90 ($20,252)
  13. 4 Open-market sale See Remarks sold 8,009 shares at an average $15.90 ($127,312)
  14. 4 Open-market sale Chief Scientific Officer sold 1,444 shares at an average $15.90 ($22,954)
  15. 4 Other disposition 10% owner disposed of 814,013 shares (other)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 19 · 365 filings